Mielóma multiplex: vizsgálatok itt: Svájc
9 of 12 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisFut, nem toborozA Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Where
- Bern, Sankt Gallen
- Életkor
- 18 év and over
- People
- 1590 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05552222 · EU 2023-503442-30-00 - 3. fázisTaking peopleA Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Where
- Bern, Sankt Gallen
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06615479 · EU 2024-515279-37-00 - 3. fázisTaking peopleA Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Where
- Bern, Winterthur
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Pfizer
See details and how to joinNCT05623020 · EU 2024-514139-50-00 - 1/2. fázisNot yet taking people in SvájcFAPI PET Imaging - An Exploratory Study
- Where
- Baden, Geneva, Genolier, Lucerne, Zurich
- Életkor
- 18 év and over
- People
- 770
- Run by
- Martin Huellner
See details and how to joinNCT07705074 - No phaseNot yet taking people in SvájcEarly Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of Zurich
See details and how to joinNCT07624760 - 3. fázisTaking peopleA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Where
- Basel, Sankt Gallen
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00 - 1/2. fázisNot yet taking people in SvájcA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Basel, Bern, Zurich
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleClinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients
- Where
- Bern
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05636787 - 2. fázisTaking peoplePRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)
- Where
- Bern
- Életkor
- 18 év and over
- People
- 100
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06430736